The Technical Analyst
Societal CDMO, Inc. [SCTL]
Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Societal CDMO, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $1.100
America/New_York / 5 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 116.13 mill |
| EPS: | -0.140 |
| P/E: | -7.86 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 105.57 mill |
| Avg Daily Volume: | 1.099 mill |
| RATING 2024-04-05 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -7.86 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.16x |
| Company: PE -7.86 | industry: PE 47.78 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.056 - 1.144 ( +/- 4.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-08 | Arens Mathew Paul | Sell | 19 676 396 | Common Stock |
| 2024-04-08 | Arens Mathew Paul | Sell | 20 000 | Stock Option (Right to Buy) |
| 2024-04-08 | Arens Mathew Paul | Sell | 1 250 000 | Pre-Funded Warrant (right to buy) |
| 2024-04-08 | Weisman Wayne | Sell | 234 982 | Common Stock |
| 2024-04-08 | Weisman Wayne | Sell | 73 620 | Common Stock |
| INSIDER POWER |
|---|
| -38.92 |
| Last 97 transactions |
| Buy: 17 853 836 | Sell: 28 337 731 |
Forecast:
16:00 - $1.090
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $1.090
Forecast 2: 16:00 - $1.090
Forecast 3: 16:00 - $1.090
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.100 (0.00% ) |
| Volume | 0.513 mill |
| Avg. Vol. | 1.099 mill |
| % of Avg. Vol | 46.64 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SCTL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SCTL
Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
Latest Press Releases
2024-04-08 16:05:00 - Press Release
Corerx, Inc. Completes Acquisition Of Societal Cdmo, Inc.
Clearwater, fla., april 08, 2024 (globe newswire) -- corerx, inc. (“corerx”) today announced that it has completed its acquisition of societal cdmo, inc. (“societal cdmo”) (nasdaq: sctl), a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics.
2024-04-08 10:10:00 - Press Release
Corerx, Inc. Completes Acquisition Of Societal Cdmo, Inc.
Clearwater, fla.--(business wire)--corerx, inc. completes acquisition of societal cdmo, inc.
2024-03-13 11:39:00 - Press Release
Societal Cdmo Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Societal Cdmo, Inc. - Sctl
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of societal cdmo, inc. (nasdaqcm: sctl) to corerx, inc. under the terms of the proposed transaction, shareholders of societal will receive $1.10 in cash for each share of societal that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the cons.
2024-03-01 14:34:00 - Press Release
Societal Cdmo Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Societal Cdmo, Inc. - Sctl
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of societal cdmo, inc. (nasdaqcm: sctl) to corerx, inc. under the terms of the proposed transaction, shareholders of societal will receive $1.10 in cash for each share of societal that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the cons.
2024-02-28 19:15:00 - Press Release
Sctl Stock Alert: Halper Sadeh Llc Is Investigating Whether The Sale Of Societal Cdmo, Inc. Is Fair To Shareholders
New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of societal cdmo, inc. (nasdaq: sctl) to corerx, inc. for $1.10 per share in cash is fair to societal cdmo shareholders. halper sadeh encourages societal cdmo shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. the investigation concerns whether societ.
Latest News
2024-02-29 07:50:23 - InvestorPlace
Why Is Societal CDMO (SCTL) Stock Up 133% Today?
Societal CDMO (NASDAQ: SCTL ) stock is rocketing higher on Thursday after the pharmaceutical development and manufacturing company announced an acquisition agreement with CoreRx. This agreement will have CoreRx acquiring Societal CDMO with a tender offer for SCTL shares.
2023-11-09 02:28:06 - Seeking Alpha
Societal CDMO, Inc. (SCTL) Q3 2023 Earnings Call Transcript
Societal CDMO, Inc. (NASDAQ:SCTL ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Stephanie Diaz - Investor Relations Group David Enloe - President & Chief Executive Officer Ryan Lake - Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital Markets Matt Hewitt - Craig-Hallum Capital Operator Good day, ladies and gentlemen, and welcome to the Societal CDMO Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
2023-11-01 16:05:00 - GlobeNewsWire
Societal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023
Webcast Scheduled for Wednesday, November 8, 2023, at 4:30 p.m. Eastern Webcast Scheduled for Wednesday, November 8, 2023, at 4:30 p.m. Eastern
2023-08-24 10:02:18 - Proactive Investors
Societal CDMO stock drops on discounted offering
Societal CDMO stock dropped more than 33% at the open after the firm announced a discounted and dilutive equity raise for gross proceeds of $8.3 million. The contract development and manufacturing organization (CDMO) announced an offering of 20,750,000 shares at $0.40 per share, a steep discount to Wednesday's share price of about $0.60.
2023-08-14 19:22:04 - Seeking Alpha
Societal CDMO, Inc. (SCTL) Q2 2023 Earnings Call Transcript
Societal CDMO, Inc. (NASDAQ:SCTL ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Stephanie Diaz - Investor Relations Group David Enloe - President and Chief Executive Officer Ryan Lake - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Jacob Johnson - Stephens Max Smock - William Blair Thomas Keller - RBC Capital Markets Operator Good day, ladies and gentlemen, and welcome to the Societal CDMO Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
2023-08-02 16:05:00 - GlobeNewsWire
Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023
Webcast Scheduled for Wednesday, August 9, 2023, at 4:30 p.m. Eastern Webcast Scheduled for Wednesday, August 9, 2023, at 4:30 p.m. Eastern
2023-05-03 16:05:00 - GlobeNewsWire
Societal CDMO to Report Financial Results for First Quarter 2023 on May 10, 2023
SAN DIEGO and GAINESVILLE, Ga., May 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will release financial results for the first quarter 2023 after the market close on Wednesday, May 10, 2023.
2023-02-22 16:05:00 - GlobeNewsWire
Societal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023
2022-11-09 20:22:07 - Seeking Alpha
Societal CDMO, Inc. (SCTL) CEO Q3 2022 Earnings Call Transcript
Societal CDMO, Inc. (NASDAQ:SCTL ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Stephanie Diaz - Investor Relations David Enloe - President and Chief Executive Officer Ryan Lake - Chief Financial Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Max Smock - William Blair Mac Etoch - Stephens Inc. Operator Good day ladies and gentlemen, and welcome to the Societal CDMO Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
2022-11-02 16:05:00 - GlobeNewsWire
Societal CDMO to Report Financial Results for Third Quarter 2022 on November 9, 2022
Webcast Scheduled for Wednesday, November 9, 2022, at 4:30 p.m. Eastern Webcast Scheduled for Wednesday, November 9, 2022, at 4:30 p.m. Eastern